Verition Fund Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.21M | Buy |
|
|||||
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $661K | Buy |
|
|||||
|
2025
Q1 | $480K | Sell |
|
|||||
|
2024
Q4 | $491K | Sell |
|
|||||
|
2024
Q3 | $493K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $346K | Sell |
|
|||||
|
2023
Q3 | $352K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $326K | Buy |
|
|||||
|
2022
Q3 | $219K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $3.76M | Buy |
|
|||||
|
2021
Q4 | $1.95M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $307K | Buy |
|